Trexquant Investment LP Sc Pharmaceuticals Inc. Transaction History

Trexquant Investment LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$3.51 - $5.21 $49,122 - $72,913	13,995 New	13,995 $60,000
Q4 2022 Feb 13, 2023	BUY	$4.02 - $7.53 $60,155 - $112,678	14,964 New	14,964 $107,000
Q4 2020 Feb 11, 2021	SELL	$5.17 - $9.41 $57,319 - $104,328	-11,087 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$7.12 - $8.86 $105,988 - $131,889	-14,886 Reduced 57.31%	11,087 $83,000
Q2 2020 Aug 07, 2020	BUY	$7.01 - $10.96 $65,143 - $101,851	9,293 Added 55.71%	25,973 $191,000
Q1 2020 May 08, 2020	BUY	$5.4 - $10.45 $90,072 - $174,306	16,680 New	16,680 $123,000

37.1M

110K

12.1K

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $95.9M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.